Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.107.120188PMID 17371805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological Inhibition of Histone Deacetylases by Suberoylanilide Hydroxamic Acid Specifically Alters Gene Expression and Reduces Ischemic Injury in the Mouse Brain

  2006cited by this paper
• Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes

  2006influential reference
• Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity

  2006cited by this paper
• Antiapoptotic and Anti‐inflammatory Mechanisms of Heat‐Shock Protein Protection

  2005cited by this paper
• Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents.

  2005cited by this paper
• Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases.

  2005cited by this paper
• The Janus Face of Cyclooxygenase-2 in Ischemic Stroke: Shifting Toward Downstream Targets

  2005cited by this paper
• Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.

  2005influential reference
• Akt Contributes to Neuroprotection by Hypothermia against Cerebral Ischemia in Rats

  2005cited by this paper
• Inducible Nitric Oxide Synthase Binds, S-Nitrosylates, and Activates Cyclooxygenase-2

  2005cited by this paper
• Clinical development of histone deacetylase inhibitors as anticancer agents.

  2005influential reference
• The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha.

  2004cited by this paper
• Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction

  2004influential reference
• Post-ischemic inflammation: molecular mechanisms and therapeutic implications

  2004cited by this paper
• CBP histone acetyltransferase activity is a critical component of memory consolidation.

  2004cited by this paper
• Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation

  2004cited by this paper
• Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids

  2004cited by this paper
• Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons

  2004influential reference
• The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin α

  2004cited by this paper
• Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia.

  2003cited by this paper
• Neurological diseases: Mechanisms, challenges and opportunities in stroke

  2003cited by this paper
• Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model

  2003influential reference
• Neuronal overexpression of cyclooxygenase‐2 increases cerebral infarction

  2003cited by this paper
• Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

  2003cited by this paper
• Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway

  2003cited by this paper
• Overexpression of HSP72 after Induction of Experimental Stroke Protects Neurons from Ischemic Damage

  2001cited by this paper
• Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

  2001cited by this paper
• Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen*

  2001cited by this paper
• Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation*

  2000influential reference
• Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB.

  2000cited by this paper
• Microglia and Macrophages Are the Major Source of Tumor Necrosis Factor in Permanent Middle Cerebral Artery Occlusion in Mice

  2000influential reference
• Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells.

  2000cited by this paper
• Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction

  2000cited by this paper
• Intrastriatal Transplantation of Bone Marrow Nonhematopoietic Cells Improves Functional Recovery After Stroke in Adult Mice

  2000cited by this paper
• Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat.

  1999cited by this paper
• The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS

  1999influential reference
• Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia.

  1998cited by this paper
• Inflammation and glial responses in ischemic brain lesions.

  1998cited by this paper
• Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat.

  1997cited by this paper
• Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene

  1997cited by this paper

• Deciphering the disease ecosystem of ischemic stroke via multi-omics and prospects for therapeutic strategies.

  2026cites this paper
• The Diverse Effect of HDAC Inhibitors: Sodium Butyrate and Givinostat on Microglia Polarization After Hypoxia-Ischemia In Vitro

  2026influential citation
• Histone and non-histone (de)acetylation impact on the blood-brain barrier

  2026cites this paper
• Unlocking the Potential of Histone Deacetylase Inhibitors in Combatting Age-Related Retinal Degenerative Diseases.

  2025cites this paper
• Comparisons in microglial responses to ischemic–hypoxic brain injury in neonatal and adult mice analyzed by transcriptome integration and deconvolution technologies

  2025cites this paper
• Therapeutic Potential of Butyrate Against Heat Stress-Induced Intestinal Damage, Systemic Inflammation, and Multiple Organ Dysfunction: Insights From In Vitro and In Vivo Experiments.

  2025cites this paper
• Epigenetic Regulation in Ischemic Neuroprotection: The Dual Role of HDACs and HATs in Neuroinflammation and Recovery

  2025cites this paper
• Uncovering a new mechanism of ischemic stroke: a study of the association between γδ T cells and immunoinflammation

  2025cites this paper
• Comparative Analysis of Systemic Inflammatory Biomarkers Across Multiple Antiseizure Medications: A Single-Center Retrospective Cohort Study of 1782 Patients

  2025cites this paper
• Therapeutic Potential of Sodium Butyrate in Neurological and Psychiatric Disorders

  2025cites this paper
• Lysine deacetylase inhibitors (KDACi) enhance the adaptability of tilapia (Oreochromis niloticus) to carbonate alkalinity stress

  2025cites this paper
• Stroke-Associated Pneumonia and the Brain-Gut-Lung Axis: A Systematic Literature Review.

  2025cites this paper
• Role of histone deacetylases and sirtuins in the ischaemic stroke: a systematic review and meta-analysis of animal studies

  2025cites this paper
• Potential therapeutic targets for ischemic stroke in pre-clinical studies: Epigenetic-modifying enzymes DNMT/TET and HAT/HDAC

  2025cites this paper
• Study on the metabolic effects of hexavalent chromium [Cr (VI)] on rat astrocytes using un-targeted metabolomics

  2024cites this paper
• The Impact of the Histone Deacetylase Inhibitor—Sodium Butyrate on Complement-Mediated Synapse Loss in a Rat Model of Neonatal Hypoxia–Ischemia

  2024cites this paper
• Sodium Butyrate, a Gut Microbiota Derived Metabolite, in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Review.

  2024cites this paper
• Immunoregulatory role of the gut microbiota in inflammatory depression

  2024cites this paper
• Uncovering Sex-Specific Epigenetic Regulatory Mechanism Involving H3k9me2 in Neural Inflammation, Damage, and Recovery in the Internal Carotid Artery Occlusion Mouse Model

  2024cites this paper
• Deciphering neuroprotective mechanism of nitroxoline in cerebral ischemia: network pharmacology and molecular modeling-based investigations

  2024cites this paper
• Butyrate as a potential therapeutic agent for neurodegenerative disorders.

  2024cites this paper
• Ischemic Stroke and the Biological Hallmarks of Aging

  2024cites this paper
• GENETIC INSIGHTS INTO SEPSIS: MENDELIAN RANDOMIZATION ANALYSIS OF CEREBROSPINAL FLUID METABOLITES

  2024cites this paper
• Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management

  2024cites this paper
• Protective effects of butyrate on cerebral ischaemic injury in animal models: a systematic review and meta-analysis

  2024influential citation
• Could MicroRNA be Neurological Prognosis Biomarkers after Cardiac Arrest?

  2024cites this paper
• Epigenetic modification of histone acetylation in the sensorimotor cortex after intracerebral hemorrhage.

  2024cites this paper
• Stress in the microbiome-immune crosstalk

  2024cites this paper
• Histone deacetylase inhibition by suberoylanilide hydroxamic acid during reperfusion promotes multifaceted brain and vascular protection in spontaneously hypertensive rats with transient ischaemic stroke.

  2024cites this paper
• SUMOtherapeutics for Ischemic Stroke

  2023cites this paper
• High-Contrast PET Imaging with [18F]NT160, a Class-IIa Histone Deacetylase Probe for In Vivo Imaging of Epigenetic Machinery in the Central Nervous System

  2023cites this paper
• Imbalance of Microbacterial Diversity Is Associated with Functional Prognosis of Stroke

  2023cites this paper
• Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?

  2023cites this paper
• Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids

  2023cites this paper
• DReAmocracy: A Method to Capitalise on Prior Drug Discovery Efforts to Highlight Candidate Drugs for Repurposing

  2023cites this paper
• Increased histone H3 acetylation inhibit the inflammatory response and activate the serum immunity of Pearl oyster Pinctada fucata martensii

  2023cites this paper
• Targeting p53 for neuroinflammation: New therapeutic strategies in ischemic stroke

  2023cites this paper
• Treatment of Status Epilepticus after Traumatic Brain Injury Using an Antiseizure Drug Combined with a Tissue Recovery Enhancer Revealed by Systems Biology

  2023cites this paper
• The Alzheimer’s Disease Brain, Its Microvasculature, and NADPH Oxidase

  2023cites this paper
• The Crosstalk between Microbiome and Mitochondrial Homeostasis in Neurodegeneration

  2023cites this paper
• Histone deacetylase inhibitor butyrate inhibits the cellular immunity and increases the serum immunity of pearl oyster Pinctada fucata martensii.

  2023cites this paper
• Epigenetic modifications in the motor cortex caused by exercise or pharmacological inhibition of histone deacetylases (HDACs) after intracerebral hemorrhage (ICH).

  2023cites this paper
• Evaluation of photobiomodulation therapy (117 and 90s) on pain, regeneration, and epigenetic factors (HDAC 2, DNMT3a) expression following spinal cord injury in a rat model

  2023cites this paper
• BML-281 promotes neuronal differentiation by modulating Wnt/Ca2+ and Wnt/PCP signaling pathway

  2023cites this paper
• New Data on the Pathophysiology of Ischemic Stroke: Epigenetic Mechanisms in Focus

  2023cites this paper
• Effect of acetate supplementation on traumatic stress-induced behavioral impairments in male rats

  2023cites this paper
• Pharmacological inhibition of histone deacetylases ameliorates cognitive impairment after intracerebral hemorrhage with epigenetic alteration in the hippocampus.

  2023cites this paper
• The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.

  2023cites this paper
• Epigenetic effects of short-chain fatty acids from the large intestine on host cells

  2023cites this paper
• Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration

  2023cites this paper
• Acetate Abates Arsenic-Induced Male Reproductive Toxicity by Suppressing HDAC and Uric Acid–Driven Oxido-inflammatory NFkB/iNOS/NO Response in Rats

  2023cites this paper
• Genome-Wide Studies in Ischaemic Stroke: Are Genetics Only Useful for Finding Genes?

  2022cites this paper
• Advancement of epigenetics in stroke

  2022cites this paper
• Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model

  2022cites this paper
• The role of short-chain fatty acids in central nervous system diseases

  2022influential citation
• The Treatment of Parkinson's Disease with Sodium Oxybate.

  2022cites this paper
• Stroke and Etiopathogenesis: What Is Known?

  2022cites this paper
• The Role of miR-20 in Health and Disease of the Central Nervous System

  2022cites this paper
• Connecting gut microbiomes and short chain fatty acids with the serotonergic system and behavior in Gallus gallus and other avian species

  2022cites this paper
• The Bridge Between Ischemic Stroke and Gut Microbes: Short-Chain Fatty Acids

  2022cites this paper
• Neuroprotective effects of sodium valproate on hippocampal cell and volume, and cognitive function in a rat model of focal cerebral ischemia.

  2022cites this paper
• Influence of Umbelliferone on the Anticonvulsant and Neuroprotective Activity of Selected Antiepileptic Drugs: An In Vivo and In Vitro Study

  2022cites this paper
• Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy.

  2022cites this paper
• The impact of the histone deacetylase inhibitor sodium butyrate on microglial polarization after oxygen and glucose deprivation

  2022cites this paper
• Mild Hypophagia and Associated Changes in Feeding-Related Gene Expression and c-Fos Immunoreactivity in Adult Male Rats with Sodium Valproate-Induced Autism

  2022cites this paper
• High-Contrast PET imaging with [18F]-NT160, a Class-IIa Histone Deacetylase (Class-IIa HDAC) Probe for In Vivo Imaging of Epigenetic Machinery in the Central Nervous System

  2022cites this paper
• Crosstalk between peripheral and the brain-resident immune components in epilepsy.

  2022cites this paper
• Histone Deacetylase Inhibitors As Cognitive Enhancers And Modifiers Of Mood And Behavior.

  2022cites this paper
• Effects of MgSO4 Alone or Associated with 4-PBA on Behavior and White Matter Integrity in a Mouse Model of Cerebral Palsy: A Sex- and Time-Dependent Study

  2022cites this paper
• Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells’ Pluripotency in Bladder Cancer

  2022cites this paper
• Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson's disease model in rats.

  2022cites this paper
• Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood–Brain Barrier After Stroke

  2022cites this paper
• A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors

  2022cites this paper
• Versatile Valproic Acid

  2022cites this paper
• Relationship between gut microbiota and lymphocyte subsets in Chinese Han patients with spinal cord injury

  2022cites this paper
• Male reproductive toxicity induced by Microcystin-leucine-arginine (MC-LR).

  2022cites this paper
• Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation

  2022cites this paper
• Analysis of Givinostat/ITF2357 Treatment in a Rat Model of Neonatal Hypoxic-Ischemic Brain Damage

  2022cites this paper
• Electroacupuncture improves TBI dysfunction by targeting HDAC overexpression and BDNF-associated Akt/GSK-3β signaling

  2022cites this paper
• Epigenetic mechanisms and potential therapeutic targets in stroke

  2022influential citation
• Suberoylanilide Hydroxamic Acid (SAHA) Reduces Glutamate-Induced Oxidative Stress in Hippocampal Cells

  2022cites this paper
• Valproic Acid Inhibits Glial Scar Formation after Ischemic Stroke

  2022cites this paper
• Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease

  2022cites this paper
• Role of Fatty Acid Chemical Structures on Underlying Mechanisms of Neurodegenerative Diseases and Gut Microbiota

  2021cites this paper
• Oxygen glucose deprivation impairs circadian clock genes expressions in Neuro 2A neuroblastoma cells unlike C6 glioma

  2021cites this paper
• Perinatal and Early-Life Nutrition, Epigenetics, and Allergy

  2021cites this paper
• Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice.

  2021cites this paper
• C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure Model

  2021cites this paper
• The Effect of Histone Deacetylase Inhibitors Panobinostat or Entinostat on Motor Recovery in Mice After Ischemic Stroke

  2021cites this paper
• The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases

  2021cites this paper
• HDAC9 Silencing Exerts Neuroprotection Against Ischemic Brain Injury via miR-20a-Dependent Downregulation of NeuroD1

  2021cites this paper
• Co-Occurrence of Symptoms and Gut Microbiota Composition Before Neoadjuvant Chemotherapy and Radiation Therapy for Rectal Cancer: A Proof of Concept

  2021cites this paper
• The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases

  2021cites this paper
• Valproic Acid Reduces Vasospasm through Modulation of Akt Phosphorylation and Attenuates Neuronal Apoptosis in Subarachnoid Hemorrhage Rats

  2021cites this paper
• Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy

  2021cites this paper
• Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination

  2021cites this paper
• Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke

  2021cites this paper
• Comparison of Two Experimental Mouse Dry Eye Models through Inflammatory Gene Set Enrichment Analysis Based on a Multiplexed Transcriptomic Approach

  2021cites this paper
• Restoration of HDAC1 Enzymatic Activity after Stroke Protects Neurons from Ischemia/Reperfusion Damage and Attenuates Behavioral Deficits in Rats

  2021cites this paper
• Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells

  2021cites this paper